Page last updated: 2024-10-29

ketoconazole and Age-Related Osteoporosis

ketoconazole has been researched along with Age-Related Osteoporosis in 2 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research Excerpts

ExcerptRelevanceReference
"Alendronate is an aminobisphosphonate that is able to increase bone mass mainly by inhibiting bone resorption."6.69Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease. ( Colao, A; Di Somma, C; Faggiano, A; Klain, M; Lombardi, G; Merola, B; Pivonello, R; Salvatore, M; Tripodi, FS, 1998)
"Alendronate is an aminobisphosphonate that is able to increase bone mass mainly by inhibiting bone resorption."2.69Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease. ( Colao, A; Di Somma, C; Faggiano, A; Klain, M; Lombardi, G; Merola, B; Pivonello, R; Salvatore, M; Tripodi, FS, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delivanis, DA1
Athimulam, S1
Bancos, I1
Di Somma, C1
Colao, A1
Pivonello, R1
Klain, M1
Faggiano, A1
Tripodi, FS1
Merola, B1
Salvatore, M1
Lombardi, G1

Trials

1 trial available for ketoconazole and Age-Related Osteoporosis

ArticleYear
Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease.
    Clinical endocrinology, 1998, Volume: 48, Issue:5

    Topics: Acute Disease; Adult; Alendronate; Antifungal Agents; Biomarkers; Bone Density; Collagen; Collagen T

1998

Other Studies

1 other study available for ketoconazole and Age-Related Osteoporosis

ArticleYear
Modern Management of Mild Autonomous Cortisol Secretion.
    Clinical pharmacology and therapeutics, 2019, Volume: 106, Issue:6

    Topics: 14-alpha Demethylase Inhibitors; Adrenal Cortex Neoplasms; Adrenal Insufficiency; Adrenalectomy; Adr

2019